Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Invest Lundbeckfond Insider Profile
11 Followers
Invest Lundbeckfond, Ten Percent Owner at Eiger Biopharmaceuticals, holds 1.43M shares in IMARA (Ticker: IMRA), holds 1.15M shares in Trevi Therapeutics (Ticker: TRVI), holds 3.18M shares in scPharmaceuticals (Ticker: SCPH).
Invest Lundbeckfond Eiger Biopharmaceuticals (EIGR)Ten Percent Owner
Eiger Biopharmaceuticals (EIGR)
Ten Percent Owner
Ranked #10,300 out of 78,624 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+32.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Invest Lundbeckfond holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 06, 2014 - Feb 06, 2015
Return:+103.10%
The most profitable trade made by Invest Lundbeckfond
Invest Lundbeckfond's Trading History
Eiger Biopharmaceuticals
Feb 06, 2014
Ten Percent Owner
Informative Buy
309.66K
$16.06M
scPharmaceuticals
Nov 21, 2017
Ten Percent Owner
Uninformative Buy
―
$28.97M
Trevi Therapeutics
May 13, 2019
Ten Percent Owner
Uninformative Buy
―
$3.55M
IMARA
Mar 16, 2020
Ten Percent Owner
Uninformative Buy
―
$41.55M
List of latest transactions for each holding click on a transaction to see Invest Lundbeckfond's performance on stock
You May Also Like
Invest Lundbeckfond insider profile FAQ
What is the percentage of profitable transactions made by Invest Lundbeckfond?
The percentage of profitable transactions made by Invest Lundbeckfond is 60%.
What is the average return per transaction made by Invest Lundbeckfond?
The average return per transaction made by Invest Lundbeckfond is 32.10%.
What stocks does Invest Lundbeckfond hold?
Invest Lundbeckfond holds: EIGR, SCPH, TRVI, IMRA stocks.
What was Invest Lundbeckfond’s latest transaction?
Invest Lundbeckfond latest transaction was an Uninformative Buy of ―.
What was Invest Lundbeckfond's most profitable transaction?
Invest Lundbeckfond’s most profitable transaction was an Informative Buy of EIGR stock on February 6, 2014. The return on the trade was 103.10%.
What is Invest Lundbeckfond's role in Eiger Biopharmaceuticals?
Invest Lundbeckfond's role in Eiger Biopharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.